WS #15164
Legal pressures are mounting on major healthcare firms, with a judge ruling that UnitedHealth (UNH) must face a shareholder suit brought by CalPERS. In a separate development, Liquidia (LQDA) shares are cratering after a court ruled in favor of competitor United Therapeutics, highlighting the severe financial risks of patent litigation in the biotech sector. Additionally, Hut 8 faces selling pressure from a director's planned share sale.
Legal & Corporate Litigation
Legal pressures are mounting on major healthcare firms, with a judge ruling that UnitedHealth (UNH) must face a shareholder suit brought by CalPERS. In a separate development, Liquidia (LQDA) shares are cratering after a court ruled in favor of competitor United Therapeutics, highlighting the severe financial risks of patent litigation in the biotech sector. Additionally, Hut 8 faces selling pressure from a director's planned share sale.